Estrogen and selective estrogen receptor modulator regulation of insulin-like growth factor binding protein 5 in the rat uterus

Gynecological Endocrinology

Volumn 16, Issue 4, 2002, Pages 265-270

  Andrade, P M ^a   Silva, I D C G ^a   Borra, R C ^a   Lima, G R ^a   Baracat, E C ^a  

^a FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

Estrogen; IGFBP 5; Raloxifene; Tamoxifen; Toremifene; Uterus

Indexed keywords

CONJUGATED ESTROGEN; ESTROGEN RECEPTOR; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; MESSENGER RNA; RALOXIFENE; SELECTIVE ESTROGEN RECEPTOR MODULATOR; SOMATOMEDIN BINDING PROTEIN 5; TAMOXIFEN; TOREMIFENE;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG EFFECT; FEMALE; GENE EXPRESSION; HORMONAL THERAPY; NONHUMAN; NUCLEOTIDE SEQUENCE; OVARIECTOMY; PRIORITY JOURNAL; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; UTERUS;

EID: 0036694013     PISSN: 09513590     EISSN: None     Source Type: Journal    
DOI: 10.1080/gye.16.4.265.270     Document Type: Article

References (33)

1. Insulin-like growth factor-binding proteins in serum and other biological fluids: Regulation and functions
2. Binding proteins for the insulin-like growth factors: Structure, regulation and function
3. Insulin-like growth factor binding proteins
4. Insulin-like growth factors and their binding proteins: Biological actions
5. Insulin-like growth factor-binding proteins
6. Insulin-like growth factor and insulin-like growth factor-binding proteins in the endometrium. Effects of intrauterine levonorgestrel delivery
7. Cellular localization and sex steroid regulation of insulin-like growth factor binding protein messenger ribonucleic acids in the primate myometrium
8. Soluble 34K binding protein inhibits the binding of insulin-like growth factor I to its cell receptors in human secretory phase endometrium: Evidence for autocrine/paracrine regulation of growth factor action
9. Histomorphometric aspects of adult castrated rat endometrium after the use of estrogen, progesterone and tamoxifen
10. Elevation of insulin-like growth factor-binding protein-1 mRNA expression following replacement therapy
11. Insulin-like growth factor system gene expression in human endometrium during the menstrual cycle
12. Studies on the mechanisms by which insulin-like growth factor-binding protein-4 (IGFBP-4) and IGFBP-5 modulate IGF actions in bone cells
13. Selective oestrogen receptor modulators
14. Estrogen receptor antagonist
15. Development of anti-estrogens and their use in breast cancer
16. Insulin-like growth factor-binding protein enhancement of insulin-like growth factor-I (IGF-I) mediated DNA synthesis and IGF-I binding in human breast carcinoma cell line
17. Insulin-like growth factor (IGF)-independent action of IGF-binding protein-3 in Hs578T human breast cancer cells - Cell surface binding and growth inhibition
18. Stimulation of endometrial cancer cell growth by tamoxifen is associated with increased insulin-like growth factor (IGF)-I induced tyrosine phosphorylation and reduction in IGF binding proteins
19. Standardization of the dose-effect of oral estrogen and progestogen in adult rats
20. Effects of tamoxifen on endometrial carcinogenesis in mice
21. The effects of raloxifene on tibia histomorphometry in ovariectomized rats
22. A two-year dietary carcinogenicity study of the anti-estrogen toremifene in Sprague-Dawley rats
23. Enhanced expression of a glyceraldehyde-3-phosphate dehydrogenase gene in human lung cancers
24. IGF binding proteins: Regulations of cellular actions
25. Suppression of uterine insulin-like growth factor binding protein 5 by estrogen is mediated in part by insulin-like growth factor I
26. Regulation and physiological role of insulin-like growth factor binding proteins
27. Insulin-like growth factor-binding protein (IGFBP)-3 and IGFBP-5 share a common nuclear transport pathway in T47D human breast carcinoma cells
28. The expression of insulin-like growth factor and its binding protein mRNA in the endometrium of postmenopausal patients with breast cancer receiving tamoxifen
29. An avaII restriction fragment length polymorphism in the insulin-like growth factor II gene and the occurrence of smooth muscle tumors
30. Insulin-like growth factor binding proteins show distinct patterns of expression in the rat uterus
31. Regulation of IGFBP-3 expression in breast cancer cells and uterus by estradiol and antiestrogens: Correlations with effects on proliferation: A review
32. Insulin-like growth factor (IGF), IGF binding protein (IGFBP), and IGF receptor gene expression and IGFBP synthesis in human uterine leiomyomata